ArticleFrontiers in psychiatry2025
Sobel neural network for EEG-based major depressive disorder screening.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early and objective screening for major depressive disorder (MDD) is crucial, with electroencephalography (EEG) offering significant potential. However, developing accurate automated tools requires architectures adept at capturing subtle, discriminative spatiotemporal features in EEG signals. This paper introduces the Sobel Network, a novel neural architecture designed specifically for EEG-based MDD screening, namely, identifying MDD patients from healthy controls (HC). Unlike approaches using Sobel operators solely for preprocessing, the Sobel Network integrates Sobel-inspired operations intrinsically within its convolutional layers, enabling end-to-end learning of features emphasizing gradient patterns and edge-like information highly relevant to depression biomarkers in EEG. We evaluate the Sobel Network on a publicly available EEG dataset from the Hospital of Universiti Sains Malaysia (HUSM). This dataset comprises 34 patients diagnosed with MDD (17 men; mean age, 40.3 ± 12.9 years) and 30 healthy controls (HC; 21 men; mean age, 38.2 ± 15.6 years). The results demonstrate that the proposed architecture significantly outperforms other deep learning models in key metrics including accuracy (achieving 98.67%), sensitivity (99.18%), and specificity (98.10%). The Sobel Network presents a promising avenue to improve the accuracy and robustness of automated EEG-based depression screening tools, offering practical impact for clinical decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.